Advertisement

Home / India / SII applies for full market authorisation of Covishield

SII applies for full market authorisation of Covishield

More than 125 crore doses have been supplied till now: Poonawalla
SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government.
SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government.
File picture

Our Bureau, PTI   |   New Delhi   |   Published 31.12.21, 03:25 PM

 

Serum Institute of India (SII) CEO Adar Poonawala on Friday said it has applied to Indian authorities for full market authorisation of Covishield, stating supplies of the Covid-19 vaccine have exceeded 125 crore doses.

Advertisement

"Supplies of the COVISHIELD vaccine in India, have exceeded 1.25 billion doses. The government of India now has enough data for full market authorisation, and therefore @SerumInstIndia has applied to the @CDSCO_INDIA_INF (DCGI) and @MoHFW_INDIA for this permission," Poonawala said in a tweet tagging the Central Drugs Standard Control Organisation (CDSCO) and Ministry of Health and Family Welfare.

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation in the country.



Advertisement
Advertisement
Advertisement
 
 
 
Copyright © 2020 The Telegraph. All rights reserved.